Journal of Critical Care
Volume 23, Issue 1 , Pages 5-10 , March 2008

The impact of ventilator-associated pneumonia on the Canadian health care system

  • John G. Muscedere, MD

      Affiliations

    • Queens University, Kingston, Canada K7L 2V7
    • ,
  • Claudio M. Martin, MD

      Affiliations

    • University of Western Ontario, Ontario, Canada N6A 4G5
    • ,
  • Daren K. Heyland, MD, MSc

      Affiliations

    • Queens University, Kingston, Canada K7L 2V7
    • Corresponding Author InformationCorresponding author. Tel.: +1 613 549 6666#3339; fax: +1 613 548 1351.

References 

  1. Weinstein RA. Nosocomial infection update. Emerg Infect Dis. 1998;4(3):http://www.cdc.gov/ncidod/eid/vol4no3/weinstein.htm
  2. Guidelines for the prevention of nosocomial pneumonia. Morb Mort Wkly Rep Recomm Rep. 1997;46:1–79
  3. Safdar N, Dezfulian C, Collard H, et al. Clinical and economic consequences of ventilator-associated pneumonia: a systematic review. Crit Care Med. 2005;33:2184–2193
  4. Safer Health Care Now. http://www.saferhealthcarenow.ca
  5. http://www.qualityhealthcarenetwork.ca
  6. http://scholar.google.com/
  7. http://www.thoracic.org
  8. http://www.sccm.org
  9. Noseworthy TW, Konopad E, Shustack A, et al. Cost accounting of adult intensive care: methods and human and capital inputs. Crit Care Med. 1996;24:1168–1172
  10. Ontario Case Cost Methodology for the daily cost of an ICU bed.
  11. The Canadian Critical Care Trials Group. A randomized trial of diagnostic techniques for ventilator-associated pneumonia. N Engl J Med. 2006;355:2619–2630
  12. http://www.statcan.ca
  13. Cook DJ, Walter SD, Cook RJ, et al. Incidence of and risk factors for ventilator-associated pneumonia in critically ill patients. Ann Intern Med. 1998;129:433
  14. Baxter A, Allan J, Bedard J, et al. Adherence to simple and effective measure reduces the incidence of ventilator associated pneumonia. Can J Anaesthesia. 2005;52:535
  15. Zuege D, Laupland K, Boiteau P, et al. Etiology of ventilator associated pneumonia in a population-based intensive care unit cohort. Am J Respir Crit Care Med. 2003;167(7):A266
  16. Davis L, McRitchie D, Badeau C, et al. Some of the hundred thousand lives saved. CHICA (Community and Hospital Infection Control Association - Canada) in Winnipeg; 2005.
  17. Kingston General Hospital, Kingston, Ontario Canada, VAP Surveillance data, Personal communication; 2004.
  18. St. Paul's Hospital, Vancouver, British Columbia, Canada. VAP Surveillance data. http://www.providencehealthcare.org2005;
  19. Calgary Health Region, VAP surveillance data, 2005, Personal communication.
  20. Needham D, Bronskill S, Sibbald W, et al. Mechanical ventilation in Ontario, 1992-2000: incidence, survival, and hospital bed utilization of noncardiac surgery adult patients. Crit Care Med. 2004;32(7):1504–1509
  21. Rapoport J, Teres D, Barnett R, et al. A comparison of intensive care unit utilization in Alberta and western Massachusetts. Crit Care Med. 1995;23:1336–1346
  22. Heyland DK, Cook DJ, Griffith L, et al. The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. Am J Resp Crit Care Med. 1999;159:1249–1256
  23. Ontario Critical Care Inventory . Incidence of ICU beds capable of mechanical ventilation was 8.3 beds/100,000 population. 2006;http://www.health.gov.on.ca/english/providers/program/critical_care/docs/report_cc_inventory.pdf
  24. Rahim MT, Milbrandt EB, Dremsizov TT, et al. Pricing critical care: an updated Russell equation [abstract]. Crit Care Med Suppl. 2004;1:P76
  25. Nseir S, Di Pompeo C, Soubrier S, et al. Impact of ventilator-associated pneumonia on outcome in patients with COPD. Chest. 2005;128:1650–1656
  26. Rincon-Ferrari MD, Flores-Cordero JM, Leal-Noval SR, et al. Impact of ventilator-associated pneumonia in patients with severe head injury. J Trauma. 2004;57:1234–1240
  27. Rello J, Ollendorf DA, Oster G, et al. Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest. 2002;122:2115–2121
  28. Shorr AF, O'Malley PG. Continuous subglottic suctioning for the prevention of ventilator-associated pneumonia: potential economic implications. Chest. 2001;119:228–235
  29. Warren DK, Shukla SJ, Olsen MA, et al. Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center. Crit Care Med. 2003;5:1312–1317
  30. Cocanour CS, Peninger M, Domonoske BD, et al. Decreasing ventilator-associated pneumonia in a trauma ICU. J Trauma. 2006;61:122–129
  31. Bregeon F, Ciais V, Carret V, et al. Is ventilator-associated pneumonia an independent risk factor for death?. Anesthesiology. 2001;94:554–560
  32. Moreno CA, Rosenthal VD, Olarte N, et al. Device-associated infection rate and mortality in intensive care units of 9 Colombian hospitals: findings of the International Nosocomial Infection Control Consortium. Infect Control Hosp Epidemiol. 2006;27:349–356
  33. Leroy O, Guilley J, Georges H, et al. Effect of hospital-acquired ventilator-associated pneumonia on mortality of severe community-acquired pneumonia. J Crit Care. 1999;14:12–19
  34. Crouch Brewer S, Wunderink RG, Jones CB, et al. Ventilator-associated pneumonia due to Pseudomonas aeruginosa. Chest. 1996;109:1019–1029
  35. Mehta RM, Niederman MS. Nosocomial pneumonia in the intensive care unit: controversies and dilemmas. J Intensive Care Med. 2003;18:175–188
  36. Miller A, Hyland M, Ofner-Agostini M, et al. The Canadian Nosocomial Infection Surveillance Program. Morbidity, mortality, and healthcare burden of nosocomial Clostridium difficile–associated diarrhea in Canadian hospitals. Infect Control Hosp Epidemiol. 2002;23:137–140
  37. Louie T. Clostridium difficile in clinical practice: increasing rates, more virulent organisms and new therapies on the horizon. Can J Infect Dis Med Microbiol. 2006;17(Suppl B):19B–24B
  38. HIV and AIDS in Canada, Surveillance report to June 2004. http://www.phac-aspc.gc.ca/publicat/aids-sida/haic-vsac0604/index.html
  39. Canadian Motor Vehicle Traffic Collision Statistics. Transp Can. 2001;http://www.tc.gc.ca/roadsafety/tp/tp3322/2001/menu.htm
  40. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control. 2004;32:470–485
  41. Carson S, Cox C, Holmes T, et al. The changing epidemiology of mechanical ventilation: a population-based study. J Intensive Care Med. 2006;21(3):173–182
  42. Needham DM, Bronskill SE, Calinawan JR, et al. Projected incidence of mechanical ventilation in Ontario to 2026: preparing for the aging baby boomers. Crit Care Med. 2005;33:574–579
  43. Tejerina E, Frutos-Vivar F, Restrepo MI, et al. Incidence, risk factors, and outcome of ventilator-associated pneumonia. J Crit Care. 2006;21:56–65
  44. Cocanour CS, Ostrosky-Zeichner L, Peninger M, et al. Cost of a ventilator-associated pneumonia in a shock trauma intensive care unit. Surg Infect. 2005;6:65–72
  45. Health Canada . The economic burden of illness in Canada. http://www.hc-sc.gc.ca
  46. Dodek P, Keenan S, Cook D, et al. Evidence based clinical based guideline for the prevention of ventilator associated pneumonia. Ann Intern Med. 2004;141:305–313
  47. Heyland DK, Cook DJ, Dodek PM. Prevention of ventilator associated pneumonia: current practice in Canadian intensive care units. J Crit Care. 2002;17:161–167
  48. Muscedere J, Heyland DK, Dodek P, et al. The prevention of ventilator associated pneumonia in Canadian critical care units. In: Presented at Toronto Critical Care Medicine Symposium, October. 2005;
  49. Zack J, Garrison T, Trovillon E, et al. Effect of an education program aimed at reducing the occurrence of ventilator-associated pneumonia. Crit Care Med. 2002;30:2407–2412
  50. Kelleghan SI, Salemi C, Padilla S, et al. An effective continuous quality improvement approach to the prevention of ventilator-associated pneumonia. Am J Infect Control. 1993;21:322–330
  51. Salahuddin N, Zafarb A, Sukhyanic L, et al. Reducing ventilator-associated pneumonia rates through a staff education programme. J Hosp Infection. 2004;57:223–227
  52. Babcock H, Zack J, Garison T, et al. An educational intervention to reduce ventilator associated pneumonia in an integrated health system: a comparison of effects. Chest. 2004;125:2224–2231
  53. http://www.ihi.org/IHI/Programs/Campaign/
  54. ABATE VAP, clinicaltrials.gov.

☆ Conflicts of interest: J Muscedere and D Heyland have received unrestricted research grants for studies in VAP unrelated to the present manuscript from Astra-Zeneca and Bayer Pharmaceuticals.

PII: S0883-9441(08)00004-X

doi: 10.1016/j.jcrc.2007.11.012

Journal of Critical Care
Volume 23, Issue 1 , Pages 5-10 , March 2008

Article Tools